Cargando…

Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances

BACKGROUND: TPN infusions are usually administered during a treatment period of 10–24 hours per day due to the metabolic capacity of the liver. During this time interval physicochemically stable TPN solution (emulsion) is needed for the treatment. The purpose of the present study was to examine how...

Descripción completa

Detalles Bibliográficos
Autores principales: Télessy, István G, Balogh, Judith, Szabó, Barnabás, Csempesz, Ferenc, Zelkó, Romána
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422991/
https://www.ncbi.nlm.nih.gov/pubmed/22591808
http://dx.doi.org/10.1186/1475-2891-11-32
_version_ 1782241068767510528
author Télessy, István G
Balogh, Judith
Szabó, Barnabás
Csempesz, Ferenc
Zelkó, Romána
author_facet Télessy, István G
Balogh, Judith
Szabó, Barnabás
Csempesz, Ferenc
Zelkó, Romána
author_sort Télessy, István G
collection PubMed
description BACKGROUND: TPN infusions are usually administered during a treatment period of 10–24 hours per day due to the metabolic capacity of the liver. During this time interval physicochemically stable TPN solution (emulsion) is needed for the treatment. The purpose of the present study was to examine how the kinetic stability features of ready-made total parenteral nutrition admixtures containing olive oil and soybean oil will change under the usage-modeling 24-hour application with and without overdose Ca(2+). METHODS: Particle size analysis and zeta potential measurements were carried out to evaluate the possible changes in the kinetic stability of the emulsions. RESULTS: Our results indicate that in two of the four mixtures bimodal droplet-size distribution figures were detected and appearance of fat particles over 5 μm can not be disclosed. The tendency for separation of large diameter droplets in the two types of oil-based emulsion systems was different. In case of soybean containing emulsion second peak of droplets appeared in the bottom of the container in contrast to the olive oil containing emulsions where the second peak appeared in the surface layer. Interestingly this phenomenon is independent of calcium-content. CONCLUSIONS: From therapeutic point the emulsions of the bigger droplets containing upper layer are safer because the potentially dangerous big droplets could remain in the infusion bag after the administration.
format Online
Article
Text
id pubmed-3422991
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34229912012-08-21 Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances Télessy, István G Balogh, Judith Szabó, Barnabás Csempesz, Ferenc Zelkó, Romána Nutr J Research BACKGROUND: TPN infusions are usually administered during a treatment period of 10–24 hours per day due to the metabolic capacity of the liver. During this time interval physicochemically stable TPN solution (emulsion) is needed for the treatment. The purpose of the present study was to examine how the kinetic stability features of ready-made total parenteral nutrition admixtures containing olive oil and soybean oil will change under the usage-modeling 24-hour application with and without overdose Ca(2+). METHODS: Particle size analysis and zeta potential measurements were carried out to evaluate the possible changes in the kinetic stability of the emulsions. RESULTS: Our results indicate that in two of the four mixtures bimodal droplet-size distribution figures were detected and appearance of fat particles over 5 μm can not be disclosed. The tendency for separation of large diameter droplets in the two types of oil-based emulsion systems was different. In case of soybean containing emulsion second peak of droplets appeared in the bottom of the container in contrast to the olive oil containing emulsions where the second peak appeared in the surface layer. Interestingly this phenomenon is independent of calcium-content. CONCLUSIONS: From therapeutic point the emulsions of the bigger droplets containing upper layer are safer because the potentially dangerous big droplets could remain in the infusion bag after the administration. BioMed Central 2012-05-16 /pmc/articles/PMC3422991/ /pubmed/22591808 http://dx.doi.org/10.1186/1475-2891-11-32 Text en Copyright ©2012 Télessy et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Télessy, István G
Balogh, Judith
Szabó, Barnabás
Csempesz, Ferenc
Zelkó, Romána
Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances
title Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances
title_full Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances
title_fullStr Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances
title_full_unstemmed Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances
title_short Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca(2+) additive under clinical application circumstances
title_sort kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose ca(2+) additive under clinical application circumstances
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422991/
https://www.ncbi.nlm.nih.gov/pubmed/22591808
http://dx.doi.org/10.1186/1475-2891-11-32
work_keys_str_mv AT telessyistvang kineticstabilityofallinoneparenteralnutritionadmixturesinthepresenceofhighdoseca2additiveunderclinicalapplicationcircumstances
AT baloghjudith kineticstabilityofallinoneparenteralnutritionadmixturesinthepresenceofhighdoseca2additiveunderclinicalapplicationcircumstances
AT szabobarnabas kineticstabilityofallinoneparenteralnutritionadmixturesinthepresenceofhighdoseca2additiveunderclinicalapplicationcircumstances
AT csempeszferenc kineticstabilityofallinoneparenteralnutritionadmixturesinthepresenceofhighdoseca2additiveunderclinicalapplicationcircumstances
AT zelkoromana kineticstabilityofallinoneparenteralnutritionadmixturesinthepresenceofhighdoseca2additiveunderclinicalapplicationcircumstances